BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9224476)

  • 1. Multidisciplinary management of refractory orbital rhabdomyosarcoma.
    Mannor GE; Rose GE; Plowman PN; Kingston J; Wright JE; Vardy SJ
    Ophthalmology; 1997 Jul; 104(7):1198-201. PubMed ID: 9224476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience.
    Fiorillo A; Migliorati R; Grimaldi M; Vassallo P; Canale G; Tranfa F; Uccello G; Fiore M; Muto P; Menna G
    Cancer; 1991 Feb; 67(3):560-3. PubMed ID: 1985749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Second-line therapy in young patients with relapsed or refractory orbital rhabdomyosarcoma.
    Zloto O; Minard-Colin V; Boutroux H; Brisse HJ; Levy C; Kolb F; Bolle S; Carton M; Helfre S; Orbach D
    Acta Ophthalmol; 2021 May; 99(3):334-341. PubMed ID: 32833335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Rhabdomyosarcoma of the orbits in childhood].
    Humpl T; Brühl K; Pitz S; de Mooy P; Bartels U; Gutjahr P
    Ophthalmologe; 1997 Dec; 94(12):914-9. PubMed ID: 9487763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical spectrum of primary ophthalmic rhabdomyosarcoma.
    Shields CL; Shields JA; Honavar SG; Demirci H
    Ophthalmology; 2001 Dec; 108(12):2284-92. PubMed ID: 11733272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Visual outcomes and late complications in paediatric orbital rhabdomyosarcoma.
    Eade E; Tumuluri K; Do H; Rowe N; Smith J
    Clin Exp Ophthalmol; 2017 Mar; 45(2):168-173. PubMed ID: 27473389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of orbital rhabdomyosarcoma (author's transl)].
    Jürgensen OA; Reinartz G; Pichler E
    Padiatr Padol; 1982; 17(2):329-39. PubMed ID: 7099686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary collaborative therapy for 30 children with orbital rhabdomyosarcoma.
    Ge X; Huang DS; Shi JT; Ma JM
    Asian Pac J Cancer Prev; 2013; 14(8):4641-6. PubMed ID: 24083717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local Resection and Brachytherapy for Primary Orbital Rhabdomyosarcoma: Outcome and Failure Pattern Analysis.
    Schoot RA; Saeed P; Freling NJ; Blank LE; Pieters BR; van der Grient JN; Strackee SD; Bras J; Caron HN; Merks JH;
    Ophthalmic Plast Reconstr Surg; 2016; 32(5):354-60. PubMed ID: 26398242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limits and chances in an unfortunate course of recurrent orbital rhabdomyosarcoma.
    Rustemeyer J; Günther L; Junker K
    Nepal J Ophthalmol; 2011; 3(2):202-5. PubMed ID: 21876600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of massive orbital involvement of intraocular retinoblastoma.
    Kiratli H; Bilgiç S; Ozerdem U
    Ophthalmology; 1998 Feb; 105(2):322-6. PubMed ID: 9479294
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative intensity-modulated brachytherapy for refractory orbital rhabdomyosarcomas in children.
    Strege RJ; Kovács G; Meyer JE; Holland D; Claviez A; Mehdorn MH;
    Strahlenther Onkol; 2009 Dec; 185(12):789-98. PubMed ID: 20013088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis of orbital rhabdomyosarcoma in children in Japan.
    Takahashi N; Minoda K
    Jpn J Ophthalmol; 1991; 35(3):292-9. PubMed ID: 1770669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localized orbital rhabdomyosarcoma. An interim report of the Intergroup Rhabdomyosarcoma Study Committee.
    Wharam M; Beltangady M; Hays D; Heyn R; Ragab A; Soule E; Tefft M; Maurer H
    Ophthalmology; 1987 Mar; 94(3):251-4. PubMed ID: 3587902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late effects of therapy in orbital rhabdomyosarcoma in children. A report from the Intergroup Rhabdomyosarcoma Study.
    Heyn R; Ragab A; Raney RB; Ruymann F; Tefft M; Lawrence W; Soule E; Maurer HM
    Cancer; 1986 May; 57(9):1738-43. PubMed ID: 3955518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
    Olivier Pascual N; Calvo JM; Abelairas Gómez JM
    Arch Soc Esp Oftalmol; 2005 Jun; 80(6):331-8. PubMed ID: 15986273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the results of treatment orbital rhabdomyosarcoma in children].
    Chipczyńska B; Grałek M; Hautz W; Kanigowska K; Kocyła-Karczmarewicz B; Trzebicka A; Kepa B
    Klin Oczna; 2007; 109(1-3):18-21. PubMed ID: 17687906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ophthalmic complications following treatment of paranasal sinus rhabdomyosarcoma in comparison to orbital disease.
    Gandhi PD; Fleming JC; Haik BG; Wilson MW
    Ophthalmic Plast Reconstr Surg; 2011; 27(4):241-6. PubMed ID: 21242849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Update of orbital rhabdomyosarcoma therapy in children].
    Ducrey N; Nenadov-Beck M; Spahn B
    J Fr Ophtalmol; 2002 Mar; 25(3):298-302. PubMed ID: 11941256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical Management of Orbital Rhabdomyosarcoma in a Referral Center in Spain.
    Bravo-Ljubetic L; Peralta-Calvo J; Larrañaga-Fragoso P; Pascual NO; Pastora-Salvador N; Gomez JA
    J Pediatr Ophthalmol Strabismus; 2016; 53(2):119-26. PubMed ID: 27018885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.